Multiple myeloma and malignant plasma cell neoplasms

CD2_MULTIPLE_MYELOMA_PLASMA_CELL

multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 C90
Hospital discharge: ICD-9 203
Hospital discharge: ICD-8 203
Cause of death: ICD-10 C90
Cause of death: ICD-9 203
Cause of death: ICD-8 203

1122

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1122

diagram downward connector

Check minimum number of events None

1122

diagram downward connector

Include endpoints None

1122

diagram downward connector
CD2_MULTIPLE_MYELOMA_PLASMA_CELL

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF8
Parent code in ICD-10 C81-C96
Name in latin Myeloma multiplex et neoplasmata maligna plasmacytorum

Summary Statistics

Key figures

All Female Male
Number of individuals 1122 505 617
Unadjusted prevalence (%) 0.32 0.25 0.39
Mean age at first event (years) 66.01 64.62 67.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits:

Survival analyses between endpoints

Plot

before Multiple myeloma and malignant plasma cell neoplasms
after Multiple myeloma and malignant plasma cell neoplasms

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Multiple myeloma and malignant plasma cell neoplasms